Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of ...

On Monday, Senate Republicans proposed major revisions of the House’s giant tax-and-spending bill. The Senate’s plan creates ...

The once-popular genetic testing company is being acquired by a nonprofit led by a 23andMe co-founder, as questions persist about how to remove personal data from it.

TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research ...

A bankruptcy judge said he’ll rule as quickly as possible on 23andMe’s proposed sale of its assets, including the genetic ...

TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million ...

Anne Wojcicki, co-founder and former CEO of 23andMe, will regain control of the embattled genetic testing company through a ...

Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...

Bambu Ventures plans to bid $10 million for 23andMe’s online health-care platform as the DNA testing firm seeks court approval to sell its assets to its cofounder and a nonprofit.

A lawsuit against 23andMe is stirring a debate about what the proper role of government is in regulating how private ...

The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...